Pemetrexed plus carboplatin versus pemetrexed in pretreated patients with advanced non-squamous non-small-cell lung cancer: treating the right patients based on individualized treatment effect prediction

R. C. M. van Kruijsdijk, F. L. J. Visseren, L. Boni, H. J. M. Groen, A. M. C. Dingemans, J. G. J. V. Aerts, Y. van der Graaf, A. Ardizzoni, E. F. Smit

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1280-1286
JournalAnnals of Oncology
Volume27
Issue number7
DOIs
Publication statusPublished - Jul 2016

Keywords

  • pemetrexed
  • carboplatin
  • NSCLC
  • prediction
  • net benefit

Cite this